Clinical trial
Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)
NCT01928927
Study timeline
Study start (actual)2014-01-01Date precision: month
Registry last updated2021-08-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV-1 Infectionunresolved
Interventions
TelmisartanDRUG · verified · RxNorm: telmisartan
Sponsors & collaborators
Mapped research locations
HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1St LouisMissouri, United States1NashvilleTennessee, United States1SeattleWashington, United States1ClevelandOhio, United States1CincinnatiOhio, United States1AuroraColorado, United States1RochesterNew York, United States1Chapel HillNorth Carolina, United States1San JuanPuerto Rico1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01928927 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.